supply of - inj glycopyrrolate 0 point 2 mg per ml ampl of 1 ml , inj dexmedetomidine 100 mcg per ml , inj ropivacaine 5 mg per ml 20 ml amp , inj bupivacaine hcl 5 mg per ml heavy amp of 4 ml , inj bupivacaine hcl 5 percent vial of 20 ml , inj ropivacaine 7 point 5 mg per ml 10 ml amp , inj diclofenac 75 mg per ml 1 ml amp , inj ropivacaine 7 point 5 mg per ml 20 ml vial , ondansetron 2 mg per ml 4ml inj , methylene blue 1 percent 10 mg perml amp of 10 ml , inj phenylepherine 10 mg 1ml , inj et

Indian Army has invited bids for the supply of - inj glycopyrrolate 0 point 2 mg per ml ampl of 1 ml , inj dexmedetomidine 100 mcg per ml , inj ropivacaine 5 mg per ml 20 ml amp , inj bupivacaine hcl 5 mg per ml heavy amp of 4 ml , inj bupivacaine hcl 5 percent vial of 20 ml , inj ropivacaine 7 point 5 mg per ml 10 ml amp , inj diclofenac 75 mg per ml 1 ml amp , inj ropivacaine 7 point 5 mg per ml 20 ml vial , ondansetron 2 mg per ml 4ml inj , methylene blue 1 percent 10 mg perml amp of 10 ml , inj phenylepherine 10 mg 1ml , inj etomidate 2 mg per ml 10ml vial , lignocaine hcl 2 percent with adrenaline 1 ratio 80000 , inj esmolol pack containing 100 mg in 10 ml vials , inj lignocaine solution hcl 2 percent for iv use , inj potassium chloride 15 percent intravenous ampoule of 10 ml - dglp re 97 ot | quantity - 13435.. Please refer to the tender document for project value and EMD details. Interested bidders can submit applications until 1 October 2026, with the technical opening scheduled for 1 October 2026.